Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility-Reference-Cited by-同舟云学术

Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility

Published:2023-04 Issue:4 Volume:163 Page:953-965
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Osman Amal M.,Mukherjee Sutapa,Altree Thomas J.,Delbeck Martina,Gehring Doris,Hahn Michael,Lang Tina,Xing Charles,Muller Thomas,Weimann Gerrit,Eckert Danny J.

Funder

National Health and Medical Research Council

Bayer Pharma AG

Bayer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference45 articles.

1. Multinight prevalence, variability, and diagnostic misclassification of obstructive sleep apnea;Lechat;Am J Respir Crit Care Med,2022

2. CPAP for prevention of cardiovascular events in obstructive sleep apnea;McEvoy;N Engl J Med,2016

3. One-year adherence to continuous positive airway pressure with telemonitoring in sleep apnea hypopnea syndrome: a randomized controlled trial;Contal;Front Med (Lausanne),2021

4. Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care;Pepin;Eur Respir J,2022

5. A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy;Horner;Respirology,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulation of the internal superior laryngeal nerve as a potential therapy for obstructive sleep apnea in a porcine model;Journal of Applied Physiology;2024-09-01

2. A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: a randomized, blinded, trial;American Journal of Physiology-Heart and Circulatory Physiology;2024-03-01

3. The Contribution of Genetic Sequencing Information to the Identification and Functional Characterization of Two-Pore Domain Potassium (K2P) Channels as Viable Therapeutic Targets;Ion Channels as Targets in Drug Discovery;2024

4. Pharmacological management of co-morbid obstructive sleep apnoea and insomnia;Expert Opinion on Pharmacotherapy;2023-12-12

5. ERS International Congress 2023: Highlights from the Sleep Disordered Breathing Assembly;ERJ Open Research;2023-11-16